Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection.

[1]  J. Kolls,et al.  Interleukin-17-dependent CXCL-13 mediates mucosal vaccine-induced immunity against tuberculosis , 2013, Mucosal Immunology.

[2]  J. Alcorn,et al.  Th17 cells mediate clade-specific, serotype-independent mucosal immunity. , 2011, Immunity.

[3]  B. Cao,et al.  IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus , 2011, Cell Research.

[4]  A. M. Houghton,et al.  IL-17RA Is Required for CCL2 Expression, Macrophage Recruitment, and Emphysema in Response to Cigarette Smoke , 2011, PloS one.

[5]  R. Rappuoli,et al.  Escherichia coli Heat-Labile Enterotoxin Promotes Protective Th17 Responses against Infection by Driving Innate IL-1 and IL-23 Production , 2011, The Journal of Immunology.

[6]  J. Alcorn,et al.  Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice , 2011, The Journal of Immunology.

[7]  C. Dong,et al.  IL-17 family member cytokines: regulation and function in innate immunity. , 2010, Cytokine & growth factor reviews.

[8]  J. Kolls,et al.  The role of Th17 cytokines in primary mucosal immunity. , 2010, Cytokine & growth factor reviews.

[9]  S. Khurana,et al.  Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus , 2010, PloS one.

[10]  P. Insel,et al.  Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax , 2010, Proceedings of the National Academy of Sciences.

[11]  T. Randall,et al.  In a Murine Tuberculosis Model, the Absence of Homeostatic Chemokines Delays Granuloma Formation and Protective Immunity1 , 2009, The Journal of Immunology.

[12]  J. Grooten,et al.  Biodegradable Polyelectrolyte Microcapsules: Antigen Delivery Tools with Th17 Skewing Activity after Pulmonary Delivery , 2009, The Journal of Immunology.

[13]  J. Rello,et al.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza , 2009, Critical care.

[14]  L. Groebe,et al.  Intranasal Immunization Promotes Th17 Immune Responses1 , 2009, The Journal of Immunology.

[15]  N. Lee,et al.  Role of cytokines and chemokines in severe and complicated influenza infections. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[16]  J. Alcorn,et al.  Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.

[17]  Jun Chang,et al.  Intranasal Delivery of Cholera Toxin Induces Th17-Dominated T-Cell Response to Bystander Antigens , 2009, PloS one.

[18]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[19]  M. Lipsitch,et al.  Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization , 2008, PLoS pathogens.

[20]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[21]  T. Tumpey,et al.  Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle , 2008, PloS one.

[22]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[23]  K. Mills,et al.  TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells1 , 2006, The Journal of Immunology.

[24]  M. Lipsitch,et al.  Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide , 2006, Infection and Immunity.

[25]  P. Kozlowski,et al.  Mucosal vaccines: the promise and the challenge , 2006, Nature Reviews Immunology.

[26]  S. Khader,et al.  IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.

[27]  T. D. Connell,et al.  Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities , 2005, Infection and Immunity.

[28]  J. Shellito,et al.  Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.

[29]  G. Francis,et al.  Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. , 1993, The Journal of clinical investigation.

[30]  J. Baker,et al.  Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. , 2010, Critical reviews in immunology.